Hims Hers Health Inc (HIMS) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally.
Total Revenue Chart for Hims Hers Health Inc
Hims Hers Health Inc (HIMS) revenue for FY2025 was USD 2.3B, a 59.0% change from FY2024. Hims Hers Health Inc's revenue grew from USD 26.7M in 2018 to USD 2.3B in 2025 (8699.6% over 7 years). Earnings per share moved from USD -1.12 in 2018 to USD -0.32 in 2022. Revenue compound annual growth rate: 5-year CAGR of 73.6%.
Total Revenue (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $6.88B
- Implied Share Price
- $30.57
- Enterprise Value
- $7.33B
- Revenue (TTM)
- $2.58B
- EBITDA
- -$10.18M
- Profit Margin
- -5.51%
- Trailing P/E
- —
- Forward P/E
- 73.53
- Price/Book (MRQ)
- 20.44
- Price/Sales (TTM)
- 2.67
- EV/EBITDA
- 205.86
- EV/Revenue
- 2.84
- Dividend Yield
- —
- Book Value
- $1.39
- Free Cash Flow (FY2025)
- $73.96M
- Free Cash Flow Yield
- 1.08%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.